Diversified Growth Company - Medtech B EUR H/  LU2304352433  /

Fonds
NAV2024-05-24 Chg.+0.1700 Type of yield Investment Focus Investment company
83.1500EUR +0.20% reinvestment Equity Worldwide NS Partners 

Investment strategy

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally. The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
 

Investment goal

The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
 

Additional info

Dieser Fonds befindet sich in Liquidation.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Health Care Equipment and Supplies (USD) index
Business year start: 01-01
Last Distribution: -
Depository bank: UBS Europe SE, Luxembourg Branch
Fund domicile: Luxembourg
Distribution permission: Switzerland, Luxembourg
Fund manager: NS Partners SA
Fund volume: 41.78 mill.  USD
Launch date: 2022-02-11
Investment focus: -

Conditions

Issue surcharge: 3.00%
Max. Administration Fee: 0.75%
Minimum investment: 3,000,000.00 EUR
Deposit fees: 0.04%
Redemption charge: 0.00%
Ongoing charges (2019-12-31): 1.90%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: NS Partners
Address: 11, Boulevard de la Foire, 1528, Luxembourg
Country: Luxembourg
Internet: www.nspgroup.com/
 

Assets

Stocks
 
100.00%

Countries

United States of America
 
77.50%
Switzerland
 
10.10%
Denmark
 
5.10%
Germany
 
4.40%
France
 
2.40%
Others
 
0.50%

Branches

Healthcare
 
100.00%